This week, Dexcom grew to become the primary medical system firm to combine generative AI right into a steady glucose monitor.
The corporate added generative AI to its Stelo glucose monitor, which it started promoting 4 months in the past. The system is an over-the-counter glucose biosensor that empowers folks — each these with and with out diabetes — to actively observe their metabolic well being.
Including generative AI to this glucose monitor will assist the system higher analyze customers’ well being information patterns, stated Dexcom COO Jake Leach.
The brand new AI platform analyzes information from quite a lot of sources — together with the Stelo biosensor, meal logging and different wearable applied sciences, he famous.
“One of many prime items of suggestions we hear from customers is that they’re in search of a extra personalised expertise. What’s distinctive about our new [generative AI] platform that’s rolling out to Stelo customers is that they’ll be capable of higher contextualize the affect of what they eat, how they sleep, way of life habits and extra on their glucose ranges,” Leach defined.
He additionally identified that the AI platform enhances the prevailing “weekly insights” characteristic inside the Stelo app. Customers will now obtain extra personalised suggestions about actions they will take to enhance their glucose management.
“As an illustration, if you happen to expertise meal spikes after sure meals or occasions of day, you’ll be able to think about a fast stroll,” Leach said. “After all, the insights will likely be tailor-made to every particular person and their private way of life decisions. My ideas will look totally different than yours. In a manner, Stelo will act as a pleasant well being ‘coach’ serving to shoppers make proactive, knowledgeable way of life selections.”
Stelo’s new generative AI capabilities are powered by Google Cloud’s AI fashions. Utilizing the tech big’s current AI fashions as a basis, Dexcom was in a position to construct its personalised platform to assemble and analyze information from totally different sources, Leach defined.
Dexcom doesn’t share any person information with Google, although, he famous.
“Tens of millions of individuals can profit from how our GenAI platform could make a long-term affect on their metabolic well being,” Leach said. “That is only the start. We imagine that AI will play a transformative function inside diabetes administration and healthcare by considerably offering a extra personalised expertise, sharing extra actionable insights and thus bettering well being outcomes for customers.”
Picture: metamorworks, Getty Photographs